FDC
Back to Balance Sheet
|
FDC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FDC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of FDC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 32.90 | |
| Mar2024 | ₹17 Cr | 55.45 | |
| Mar2023 | ₹11 Cr | -31.06 | |
| Mar2022 | ₹16 Cr | 47.83 | |
| Mar2021 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,837.2 Cr | -4.4% | -16% | -24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -4.4% |
-16% |
-24.3% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses